Veeva Systems Stock Earnings Reports

Veeva reported a strong Q2 (total revenue $789M) beating guidance and raised full-year billings guidance (annual billings +$35M). Management highlighted continued broad-based execution: R&D subscriptions showed notable upside, Crossix (commercial analytics/audience product) remains a meaningful growth driver, and commercial product momentum is strengthening. The major corporate development was the long-awaited settlement with IQVIA, which removes historical restrictions (including data limitations and OEM constraints tied to Salesforce) and is expected to materially expand Veeva's commercial cloud opportunity over time by enabling deeper data, analytics (Nitro), and network integrations. Vault CRM migrations and wins continue (9 top-20 customers committed; two top-20 go-lives in major markets this quarter), with management emphasizing a multi-year migration cadence (bulk of migrations expected in 2026–2027). Veeva AI (agent/agent interoperability via the Vault platform and MCP) is presented as a foundational, industry-specific advantage; management expects the AI initiative to expand market opportunity significantly but to contribute little revenue in 2026–2027 while they work with early adopters and scale the agent ecosystem. Margins: short-term transition costs for Vault CRM migrations may modestly increase COGS, but longer-term COGS should improve. Management reiterated disciplined, platform-first product execution and that annual billings (not quarterly billings) are the better metric for execution. Investor takeaways: the IQVIA resolution materially de-risks and enlarges the commercial cloud TAM over time; AI is positioned as a multi-year strategic growth driver (high upside but near-term limited revenue); execution on Vault CRM migrations, R&D subscriptions, and Crossix are the key drivers to monitor for near-term revenue and billings upside.